Polaryx Therapeutics (PLYX) : 3-week performance

Polaryx Therapeutics, Inc. engages in the manufacturing of biotechnology products. Its pipeline of products includes PLX-100, PLX-200, and PLX-300. 

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 11
• Founded by Hahn-Jun Lee in 2014 
• HQ: Paramus, New Jersey
• https://polaryx.com

The company focuses on developing patient-friendly, orally available small molecule therapies (and some gene therapy candidates) for rare pediatric lysosomal storage disorders (LSDs), such as neuronal ceroid lipofuscinosis (e.g., CLN2, CLN3), Krabbe disease, Sandhoff disease, and others.

• Lead Candidate: PLX-200 (a repurposed oral small molecule, e.g., based on gemfibrozil) targets multiple LSDs by promoting lysosome biogenesis, reducing inflammation, and protecting neuronal function.
• Pipeline: Includes PLX-100, PLX-300 (preclinical combinations), and PLX-400 (preclinical gene therapy).

TreeHouse Foods (NYSE: THS)

New York Stock Exchange (NYSE) under the ticker symbol THS on June 28, 2005, following its spin-off from Dean Foods. 

Trading and Corporate History

Ticker Symbol: THS
Origin: Incorporated in January 2005 as a spin-off of Dean Foods' specialty foods business.
Going Private: The company was acquired by the European investment firm Investindustrial and delisted from the NYSE on February 11, 2026, becoming a private company. 

ZIM Integrated Shipping (ZIM) to be acquired by Hapag-Lloyd for $35 per share in $4.2 bln cash deal

 

 

 

 

• Chart the day before, Fri 13 Feb 2026 

 

  

Hapag-Lloyd (OTC: HPGLY) is buying Israeli competitor Zim Integrated Shipping Services for $4.2 billion as the shipping firm looks to bolster its capacity.

Germany-based Hapag-Lloyd said Monday that it signed a deal to buy Zim for $35 a share in cash, a 58% premium to Zim’s closing price of $22.20 on Friday. The total deal price of around $4.2 billion will be funded from cash reserves and external financing of up to $2.5 billion.

The combined business will have a standing capacity of more than 3 million twenty-foot equivalent units, the standard form of measurement in container shipping, and more than 400 vessels. Hapag-Lloyd currently has vessel capacity of 2.5 million TEU and 305 vessels, according to the company’s website.

The deal is expected to be completed by the end of this year, Hapag-Lloyd said. Any deal will require the consent of the state of Israel, Zim shareholders and regulators.

Zim is considered a strategic asset for the Israeli state. As part of the deal, Israel’s special stake in Zim will be transferred to a carved-out container business, which will be owned by Israeli private-equity firm FIMI, Hapag-Lloyd said. The new container line will start with 16 vessels, according to Hapag-Lloyd.

The move comes after Zim appointed an independent board that has spent the last several months conducting a strategic review to assess a range of options, including a sale of the company, capital allocation options and other measures to maximize shareholder value.

Zim recently reported a sharp drop in third-quarter earnings as freight rates tumbled and container volumes slipped, with the company warning that fourth-quarter conditions had weakened.